Bayer Ag · XETR:BAYN
Bayer — Corporate Update (July 2021)
12 slides from Bayer's corporate update, Jul 29, 2021
Slide 1: Glyphosate Five-Point-Plan Litigation Update
Glyphosate Five-Point-Plan Litigation Update /////////// 29 July 2021 1 Glyphosate Five-Point-Plan /// Litigation Update /// 29 July 2021
Slide 2: Objectives
Provide an update to the market… …on our Five-Point-Plan to address potential future RoundupTM claims ahead of anticipated August U.S. Supreme Court writ filing Recap on 27 May… … when Bayer made the decision to withdraw from the national class process to Objectives improve control of future scenari
Slide 3: Cautionary Statements Regarding Forward-Looking Information
Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the ac
Slide 4: Recap May '21: Five-Point-Plan aims to effectively address potential future Roundup claims
Recap May ‘21: Five-Point-Plan aims to effectively address potential future RoundupTM claims 1 Continue to be open to settlement discussions to resolve claims and bring an end to litigation & liability risk 2 Continue ongoing appeals (Hardeman, Pilliod, Carson) to aim for significantly reducing futu
Slide 5: We will file our petition of the Hardeman case in August 2021
We will file our petition of the “Hardeman case” in August 2021 to the U.S. Supreme Court Mid-2022 U.S. Scenario 1 Favorable Supreme Court Favorable case ruling August 2021 Late 2021 / early 2022 U.S. U.S. Supreme Court Supreme Court writ filing writ ruling Scenario 2 Unfavorable 5 Glyphosate Five-P
Slide 6: Selective engagement in settlements only until petition is accepted
Selective engagement in settlements only until petition is accepted Short-term (until 2021) Continue further settlement discussions of ~30,000 inventory cases Present cases Negotiate & Re-assess each case and enforce selective settlement approach settle existing claims No further settlements after U
Slide 7: Scenario 2: Claims Administration program will allow to manage potential longer-term tail
Scenario 2: Claims Administration program will allow to manage potential longer-term tail Mid- to long-term (2022 onwards) Consider longer-term impacts of new claims in absence of possible positive U.S. Supreme Court ruling (Scenario 2) Future cases1 Scenario 1 Scenario 2 U.S. U.S. Set up a Claims A
Slide 8: Additional gross provision of $4.5 bn accounted for in Q2 2021
Additional gross provision of $ 4.5 bn (~ € 3.8 bn) accounted for in Q2 2021 Mid- to long-term NHL cases per year based on National Cancer Institute incidence (2022 onwards) statistics Epidemiology Current inventory statistics as a base for % of alleged NHL cases related to glyphosate Future cases1
Slide 9: Long-term measures taken to essentially eliminate the base for new claims post-latency
Long-term measures taken to essentially eliminate the base for new claims post-latency Long-term (~2037 onwards) Glyphosate-based products for U.S. residential market Start to replace all glyphosate-based products for the U.S. residential market with non-glyphosate alternatives in 2023 Post-latency
Slide 10: Summary
We are in control of the process and have taken clear action to allow investors to focus on the long-term intrinsic value of Bayer We are moving forward with a clear legal defense strategy to manage our short-term and medium-term exposure Summary We are taking decisive action to limit any potential
Slide 11: Thank you
Thank you /////////// CONFIDENTIAL – ATTORNEY CLIENT PRIVILIDGED WORK PRODUCT
Slide 12: We will file our petition of the Hardeman case in August 2021
We will file our petition of … in August 2021 the “Hardeman case”… to the U.S. Supreme Court Timeline Federal preemption 27 March Question, whether state-based failure-to-warn claims central to 2019 Verdict $ 80.3 m this litigation are barred under FIFRA 15 July FIFRA expressly prohibits states from